A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
Clinical trial NCT04089735 · COMPLETED
Trial details
- NCT number
- NCT04089735
- Sponsor
- Formosa Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2020-04-07
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.